Results 291 to 300 of about 682,776 (395)
A Manual of the Diseases of the Eye, a Treatise on Ophthalmology [PDF]
Squier Littell
openalex +1 more source
ABSTRACT Background Head and neck cancer (HNC) significantly impacts older adults, with mortality influenced by multiple factors. The Multidimensional Prognostic Index (MPI), derived from comprehensive geriatric assessment (CGA), may improve risk stratification and clinical decision making. Methods An observational cohort study was conducted at Erasmus
Ajay T. Bakas+5 more
wiley +1 more source
Tegmen dehiscence precipitated by barotrauma in idiopathic intracranial hypertension. [PDF]
Cao EM+6 more
europepmc +1 more source
ABSTRACT Objective Oral cavity carcinomas (OCCs) represent roughly 50% of all head and neck cancers. The risk of occult neck metastases for early‐stage OCCs ranges from 15% to 35%, hence the need to develop tools that can support the diagnosis of detecting these neck metastases.
Stefania Troise+12 more
wiley +1 more source
Structural OCT Changes Following Repeated Low-Level Red-Light Therapy for Myopia Prevention.
Zhang Z+5 more
europepmc +1 more source
Correction: Radiotherapy has a survival advantage over surgery in patients with choroidal melanoma: a retrospective cohort study of 6,871 patients. [PDF]
Wu Y+5 more
europepmc +1 more source
ABSTRACT Background Adenoid cystic carcinoma (ACC) is the second most common and treatment‐resistant salivary gland carcinoma (SGC). Although platinum‐based therapies are effective, the efficacy of eribulin, a microtubule inhibitor with an 18% response rate in a Phase II trial involving recurrent/metastatic SGC, in patients with advanced ACC after ...
Tomomi Sanomachi+16 more
wiley +1 more source
ABSTRACT Background The NTRK fusion gene is detected in most salivary gland secretory carcinomas. While tropomyosin receptor kinase (TRK) inhibitors are used for various solid tumors with the fusion gene, there are no reports regarding TRK inhibitor use for unresectable parotid gland carcinomas that subsequently shrink and become resectable.
Arisa Nagano+11 more
wiley +1 more source
Biometric Factors in the VRF-G Formula for IOL Power Calculation. [PDF]
Voytsekhivskyy OV+6 more
europepmc +1 more source